Geode Capital Management
IONS icon

Geode Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$114M Buy
2,891,095
+48,141
+2% +$1.9M 0.01% 946
2025
Q1
$85.8M Buy
2,842,954
+155,706
+6% +$4.7M 0.01% 1063
2024
Q4
$94M Buy
2,687,248
+18,890
+0.7% +$661K 0.01% 1038
2024
Q3
$107M Buy
2,668,358
+183,814
+7% +$7.37M 0.01% 956
2024
Q2
$118M Buy
2,484,544
+120,288
+5% +$5.73M 0.01% 815
2024
Q1
$103M Buy
2,364,256
+88,325
+4% +$3.83M 0.01% 905
2023
Q4
$115M Buy
2,275,931
+81,200
+4% +$4.11M 0.01% 785
2023
Q3
$99.6M Buy
2,194,731
+37,863
+2% +$1.72M 0.01% 795
2023
Q2
$88.5M Buy
2,156,868
+86,918
+4% +$3.57M 0.01% 861
2023
Q1
$74M Buy
2,069,950
+57,227
+3% +$2.05M 0.01% 923
2022
Q4
$76M Buy
2,012,723
+111,580
+6% +$4.21M 0.01% 869
2022
Q3
$84.1M Buy
1,901,143
+36,010
+2% +$1.59M 0.01% 751
2022
Q2
$69M Sell
1,865,133
-32,359
-2% -$1.2M 0.01% 901
2022
Q1
$70.3M Buy
1,897,492
+72,266
+4% +$2.68M 0.01% 1000
2021
Q4
$55.5M Buy
1,825,226
+52,459
+3% +$1.6M 0.01% 1229
2021
Q3
$59.5M Buy
1,772,767
+10,227
+0.6% +$343K 0.01% 1132
2021
Q2
$70.3M Buy
1,762,540
+33,394
+2% +$1.33M 0.01% 1024
2021
Q1
$77.6M Buy
1,729,146
+56,942
+3% +$2.56M 0.01% 909
2020
Q4
$94.4M Buy
1,672,204
+81,910
+5% +$4.63M 0.02% 722
2020
Q3
$75.4M Buy
1,590,294
+56,509
+4% +$2.68M 0.01% 713
2020
Q2
$90.4M Buy
1,533,785
+42,720
+3% +$2.52M 0.02% 601
2020
Q1
$70.4M Buy
1,491,065
+47,323
+3% +$2.24M 0.02% 615
2019
Q4
$87.1M Buy
1,443,742
+15,705
+1% +$948K 0.02% 668
2019
Q3
$85.5M Sell
1,428,037
-133,960
-9% -$8.02M 0.02% 631
2019
Q2
$100M Buy
1,561,997
+145,075
+10% +$9.32M 0.02% 560
2019
Q1
$115M Buy
1,416,922
+75,489
+6% +$6.13M 0.03% 509
2018
Q4
$72.5M Buy
1,341,433
+82,152
+7% +$4.44M 0.02% 584
2018
Q3
$65M Buy
1,259,281
+104,516
+9% +$5.39M 0.02% 681
2018
Q2
$48.1M Buy
1,154,765
+61,723
+6% +$2.57M 0.01% 781
2018
Q1
$48.2M Buy
1,093,042
+18,912
+2% +$834K 0.02% 752
2017
Q4
$54M Buy
1,074,130
+24,499
+2% +$1.23M 0.02% 675
2017
Q3
$53.2M Buy
1,049,631
+22,431
+2% +$1.14M 0.02% 647
2017
Q2
$52.3M Buy
1,027,200
+79,294
+8% +$4.03M 0.02% 636
2017
Q1
$38.1M Buy
947,906
+75,027
+9% +$3.02M 0.02% 761
2016
Q4
$41.7M Buy
872,879
+54,751
+7% +$2.62M 0.02% 661
2016
Q3
$30M Buy
818,128
+24,460
+3% +$896K 0.02% 749
2016
Q2
$18.5M Buy
793,668
+32,717
+4% +$762K 0.01% 1000
2016
Q1
$30.8K Buy
760,951
+31,981
+4% +$1.3K 0.02% 701
2015
Q4
$45.1M Buy
728,970
+3,590
+0.5% +$222K 0.03% 552
2015
Q3
$29.3M Buy
725,380
+16,287
+2% +$658K 0.02% 699
2015
Q2
$40.8M Sell
709,093
-58,954
-8% -$3.39M 0.02% 593
2015
Q1
$48.9M Buy
768,047
+59,875
+8% +$3.81M 0.03% 530
2014
Q4
$43.7M Buy
708,172
+5,861
+0.8% +$362K 0.03% 537
2014
Q3
$27.3M Buy
702,311
+20,477
+3% +$795K 0.02% 689
2014
Q2
$23.5M Sell
681,834
-1,752
-0.3% -$60.4K 0.02% 762
2014
Q1
$29.5M Buy
683,586
+29,543
+5% +$1.28M 0.02% 640
2013
Q4
$26.1M Buy
654,043
+111,036
+20% +$4.42M 0.02% 659
2013
Q3
$20.4M Buy
543,007
+55,385
+11% +$2.08M 0.02% 691
2013
Q2
$13.1M Buy
+487,622
New +$13.1M 0.01% 816